Global Research Antibodies and Reagents Market

Research Antibodies and Reagents Market Size, Share, Growth Analysis, By Technology(western blotting, flow cytometry, ELISA, Immunohistochemistry), By Application(proteomics, drug development and Genomics), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35H2053 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 66 | Figures: 75

Research Antibodies and Reagents Market News

  • Located at Monash University in Malaysia, Agilent Technologies, Inc. (US) announced in August 2023 the inauguration of a new, full-scale Integrated Biology Center. The facility's main goal is to strengthen regional capacities for accelerating life science research and development (R&D). 
  • The definitive agreement for Danaher (US) to purchase all Abcam plc's (UK) outstanding shares was signed in August 2023. Abcam is anticipated to function as an independent business inside Danaher's Life Sciences division because of this development. 
  • Bio-Techne Corporation declared in July 2023 that the acquisition of Lunaphore had been completed. This decision was made with the intention of strengthening the companies' leadership in spatial biology within the domains of translational and clinical research. 
  • Cell Signaling Technology (CST) and Lunaphore announced their collaboration in June 2023. The goal of this project was to make it possible for Lunaphore to deploy CST antibodies on the COMET platform, bolstering fully automated spatial biology. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Research Antibodies and Reagents Market size was valued at USD 12.7 Billion in 2023 and is poised to grow from USD 13.55 Billion in 2024 to USD 22.76 Billion by 2032, growing at a CAGR of 6.70% during the forecast period (2025-2032).

the research antibodies and reagents market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Thermo Fisher Scientific, Inc.', 'Abcam plc.', 'Merck KGaA', 'Bio-Rad Laboratories, Inc.', 'Cell Signaling Technology, Inc.', 'Agilent Technologies, Inc.', 'F. Hoffmann-La Roche Ltd.', 'Santa Cruz Biotechnology, Inc.', 'GE Healthcare Life Sciences', 'BD Biosciences', 'BioLegend, Inc.', 'R&D Systems, Inc.', 'Sigma-Aldrich Corporation', 'Lonza Group Ltd.', 'Promega Corporation', 'Qiagen N.V.', 'Affymetrix, Inc.', 'Novus Biologicals, LLC', 'Enzo Life Sciences, Inc.', 'OriGene Technologies, Inc.'

Research and innovation depend on collaboration between academic institutions and the R&D departments of businesses. These partnerships guarantee the movement of information and technology from the academic world to the business world and vice versa. The number of such collaborations has greatly increased as a result of the escalating economic volatility and the quickening pace of technological change. Due to the numerous uses for research-specific antibodies, Reagents, market participants are concentrating on working with academic institutions to promote student and researcher awareness of new analytical technology.

Many diseases are now being detected, categorised, and treated differently thanks to personalised medicine, which has emerged as a key topic of research in the healthcare sector. In oncology, these developments are particularly noticeable. Additionally, over the past five years, biopharmaceutical companies have almost doubled their R&D expenditures in personalized medicine; during the following five, this expenditure is predicted to rise by 33%. Rapid, highly sensitive, and quantitative approaches to examine proteins and associated post-translational alterations in clinical specimens are now more important than ever as personalized medicine gains popularity and helps to define individual patient treatments. Additionally, because gene variants might predict a patient's propensity to respond to a certain medicine, researchers are concentrating on identifying and understanding different proteins. Changes, genetic variations, and their connection to various diseases.

The market for research antibodies and reagents is dominated by North America due to an increase in investments for the creation of structure-based medication designs, a focus on research projects involving proteins, related biomolecules, and genes, and an expansion of research and development activities in the genomics and proteomics fields.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Antibody Production Market
Buy Now GET FREE SAMPLE
Chromatography Reagent Market
Buy Now GET FREE SAMPLE
Monoclonal Antibody Therapy Market
Buy Now GET FREE SAMPLE
Monoclonal Antibodies Market
Buy Now GET FREE SAMPLE
Protein Assays Market
Buy Now GET FREE SAMPLE
Medical Imaging Reagents Market
Buy Now GET FREE SAMPLE
Protein Therapeutics Market
Buy Now GET FREE SAMPLE
Immunology Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Research Antibodies and Reagents Market

Report ID: SQMIG35H2053

$5,300
BUY NOW GET FREE SAMPLE